TEAM REPORTS (HOMESTEAD) - Kyle Krisiloff, No. 14, Lilly/Walgreens, HMS Preview
 |
Krisiloff, who has competed in nine 1.5-mile events this season with an average finish of 29th, is excited to make his debut at the Florida track known for its season finales. As the only driver to get behind the wheel of the No. 14 Lilly/Walgreens Ford Fusion during the 2007 season, Krisiloff has 34 consecutive Busch Series starts to guide him as he faces the competition on the track for the first time.
³Homestead-Miami Speedway is the last race track the NASCAR Series competes on, and the last track that I have yet to run on in my Busch Series career,² Krisiloff said. ³I am excited to finally have the opportunity to race there this weekend, and I look forward to a great race. We are bringing the same car we had in Texas, and hopefully this time we can get a good run in the season finale.²
Entering the 2007 season as one of many new teams, Krisiloff and the Carl A. Haas Motorsports team were prepared for the many ups and downs the team would deal with in its first season, but there was added pressure for Krisiloff as he geared up for his first full-season in the NBS.
³This season has been tough on us,² Krisiloff said. ³It has been tough on me, and it has been tough on my guys. We have had to deal with being a one-car team with limited resources all year. I want to thank everyone for working hard all season and never giving up. I have enjoyed representing Lilly and Walgreens this season, and I feel honored to have been involved with the Racing Against Diabetes campaign helping to educate and inform the NASCAR community about diabetes. Hopefully we can end the season on a positive note with a great finish at Homestead.²
Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the worldıs most urgent medical needs.
Walgreens Co. is the nationıs largest drugstore chain with fiscal 2006 sales of $47.4 billion. The company operates 5,850 stores in 48 states and Puerto Rico, including 77 Happy Harryıs drugstores in Delaware and surrounding states. Walgreens is expanding its patient-first health care services beyond traditional pharmacy through Walgreens Health Services, its managed convenient care clinics inside drugstores. Walgreens Health Services assists pharmacy patients and prescription drug and medical plans through Walgreens Health Initiatives, Inc. (a pharmacy benefits manager), Walgreens Mail Service Inc., Walgreens home Care Inc., and Walgreens Specialty Pharmacy.
Joslin Diabetes Center, affiliated with Harvard Medical School, has helped revolutionize the diagnosis, treatment and prevention of diabetes since itıs founding more than a century ago. Joslin is the worldıs largest diabetes research center, diabetes clinic, and provider of diabetes education, and its staff of renowned physicians, researchers and clinical specialists is dedicated to preventing and curing diabetes. Joslin and Walgreens have a multi-year partnership to develop and deliver awareness, wellness, prevention and education programs to Walgreens customers with diabetes.
Racing Against Diabetes, a public awareness campaign sponsored by Eli Lilly and Company and Walgreens, is designed to educate people at risk for and living with diabetes. Diabetes is the sixth leading cause of death in the United States, affecting nearly 21 million Americans; yet, one-third of those affected are unaware they have the disease. Seeking to build diabetes awareness both on and off the track, the Racing Against Diabetes campaign hosts diabetes education programs in NASCAR race markets across the country. The first cause-marketing effort of its kind in the NASCAR Busch Series, Racing Against Diabetes works alongside the Joslin Diabetes Center, the worldıs largest diabetes research center/clinic and provider of diabetes education.